Additional provisions

(a) Clarification The participation of the Secretary in developing and updating the list of essential medicines under section 2 shall be deemed to be full satisfaction of the requirements applicable to such secretary under section 3 of Executive Order 13944 (85 Fed. Reg. 49929). (b) Confidential commercial information The exchange of information among the Secretary and the heads of other relevant Federal departments and agencies for purposes of carrying out sections 3 and 4 shall not be a violation of section 1905 of title 18, United States Code. This section shall not be construed to affect the status, if any, of such information as trade secret or confidential commercial information for purposes of section 301(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331(j)), section 552 of title 5, United States Code, or section 1905 of title 18, United States Code. (c) Cybersecurity measures The Secretary shall ensure that robust cybersecurity measures are in place to prevent inappropriate access to, or unauthorized disclosure of, the information identified, exchanged, or disclosed under sections 3 and 4.